Alzheimer's Disease Virtual Symposium

The Impact of COVID-19 on Individuals Living with Alzheimer’s Disease

Presented by Stony Brook Center of Excellence for Alzheimer’s Disease

Friday, November 5
8 – 11 am

Webinar will be held via Zoom. Earn CMEs, NCPDs, CEUs. 

Register Now

The COVID pandemic presents unique risks to people with Alzheimer's disease and dementia from higher rates of psychiatric symptoms to neuropsychiatric disturbances, social isolation and grief. This symposium will discuss the impact of COVID-19 on prevalence, risk factors, and types of psychiatric signs and symptoms. It will also review potential treatments to improve these symptoms and offer providers and caregivers helpful resources, cognitive exercises and coping skills to improve the physical and mental health of these individuals. 

All healthcare professionals and members of the community are invited.


Post-acute Cognitive Symptoms and Potential Mechanisms in SARS-CoV-2 Infection and Relationships to Alzheimer’s Disease and Related Dementias
Sara Weisenbach, PhD, ABPP
Associate Professor of Psychiatry & Behavioral Health
Stony Brook Center of Excellence for Alzheimer’s Disease, Stony Brook Neurosciences Institute

This presentation will summarize what is known about the most common cognitive problems in post-acute SARS-CoV-2, discuss potential causes for cognitive changes in older adults and describe new longitudinal studies that will monitor cognitive symptoms and neurobiology in post-acute SARS-CoV-2.

Psychiatric Symptoms Associated with COVID-19 in Individuals with Alzheimer’s Disease and Related Dementias
Nikhil Palekar, MD
Associate Professor of Psychiatry, Director, Geriatric Psychiatry
Medical Director, Stony Brook Center of Excellence for Alzheimer’s Disease, Stony Brook Neurosciences Institute

This presentation will discuss the prevalence, risk factors, types of psychiatric manifestations and its impact on individuals living with Alzheimer’s disease and related dementias along with potential treatments to ameliorate these symptoms.

Grieving During The Pandemic And The Role of Palliative Care In Helping Care for Alzheimer’s Patients and Their Families Affected By COVID -19
Grace La Torre, DO, MS
Director, Palliative Care Service, Stony Brook University Hospital
Program Director, Hospice & Palliative Medicine Fellowship
Director, Hospice & Palliative Medicine Education and Clerkships
Assistant Professor of Clinical Medicine
Department of Medicine, Division of Hematology and Oncology, Stony Brook Medicine

This presentation will discuss the natural process of grieving, the impact of the pandemic on this process and the role of palliative care in helping support these patients and their families.

Neurocognitive Health
Nicole Absar, MD
Diplomate, Behavioral Neurology & Neuropsychiatry
Board Certified by American Board of Psychiatry & Neurology
Clinical Assistant Professor, Renaissance School of Medicine at Stony Brook University
Stony Brook Center of Excellence for Alzheimer’s Disease, Stony Brook Neurosciences Institute

This presentation will provide an overview of the neuroscience of the brain and neurocognitive health interventions, including implementing a lifestyle change and holistic health strategies with brain healthy foods/ MIND diet; physical, mental and cognitive exercises including yoga therapy; meditation, mindfulness and stress management to overall improve mental, physical and cognitive health and quality of life and ultimately to slow down the progression of dementia. 

Register Now

The link to this course will be sent to the email used to register.

This is a free educational opportunity. This Alzheimer’s Symposium is supported in part by a grant from the New York State Department of Health.